menu
    • menu

    Company profile for Biofrontera

    NEW Drugs in Dev: 5
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biofrontera Inc. is a pharmaceutical company, specializing in high quality dermatological products for the care and treatment of skin diseases. Biofrontera’s primary focus is on the development and commercialization of novel therapies for non-melanoma skin cancer. The entire team at Biofrontera consists of highly motivated and exceptionally committed people, aiming to provide high quality products and great service for docto...
    Biofrontera Inc. is a pharmaceutical company, specializing in high quality dermatological products for the care and treatment of skin diseases. Biofrontera’s primary focus is on the development and commercialization of novel therapies for non-melanoma skin cancer. The entire team at Biofrontera consists of highly motivated and exceptionally committed people, aiming to provide high quality products and great service for doctors and their patients. Biofrontera headquarters are located in Leverkusen, Germany, and Biofrontera Inc. has its offices near Boston, MA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BiofronteraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    201 Edgewater Dr Ste 210 Wakefield, MA 01880
    Telephone
    Telephone
    1-844-426-3589
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biofrontera-us.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/biofrontera-pharma-gmbh
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/biofrontera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Village de la Chimie

    Not Confirmed

    envelop Contact Supplier

    Village de la Chimie

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biofrontera Reports Successful Phase 3 Trial For Ameluz® PDT
    Biofrontera Reports Successful Phase 3 Trial For Ameluz® PDT

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234622/0/en/Biofrontera-Announces-Positive-Results-in-Phase-3-Study-of-Ameluz-PDT-for-Actinic-Keratoses-on-the-Extremities-Neck-and-Trunk-Meeting-Primary-Endpoint.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Biofrontera Reports Record Q4 2025 Revenues Of $17.0M-$17.5M
    Biofrontera Reports Record Q4 2025 Revenues Of $17.0M-$17.5M

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217820/0/en/Biofrontera-Inc-Announces-Record-Preliminary-Fourth-Quarter-2025-Revenues-between-17-0-Million-and-17-5-Million-Representing-Approximately-35-Year-Over-Year-Growth.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Biofrontera Announces Database Locks For Clinical Studies
    Biofrontera Announces Database Locks For Clinical Studies

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215399/0/en/Biofrontera-Inc-Announces-Data-Base-Locks-for-Two-Clinical-Studies-Supporting-Key-Data-and-Regulatory-Milestones.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Biofrontera Completes Ameluz & Rhodoled Transfer FDA Approval
    Biofrontera Completes Ameluz & Rhodoled Transfer FDA Approval

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207743/0/en/Biofrontera-Inc-Completes-Transfer-of-Ameluz-and-RhodoLED-FDA-approval-and-Associated-Intellectual-Property-Portfolio.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Biofrontera Completes Phase 1 Ameluz Study for Actinic Keratoses
    Biofrontera Completes Phase 1 Ameluz Study for Actinic Keratoses

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199836/0/en/Last-Patient-Completes-Biofrontera-s-Phase-1-Pharmacokinetics-Study-of-Ameluz-for-Treatment-of-Actinic-Keratoses-on-the-Trunk-and-Extremities.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Biofrontera Filed of sNDA for Treatment of sBCC with Ameluz®-PDT
    Biofrontera Filed of sNDA for Treatment of sBCC with Ameluz®-PDT

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197970/0/en/Biofrontera-Inc-Announces-Filing-of-Supplemental-New-Drug-Application-sNDA-for-the-Treatment-of-Superficial-Basal-Cell-Carcinoma-sBCC-with-Ameluz-PDT.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search